Abstract
There is only little information about the role of mutations of the thymidine kinase (TK) and DNA polymerase (pol) genes of herpes simplex virus type 2 (HSV-2) for the development of antiviral resistance. In this study, the polymorphism of TK and DNA pol genes was examined in 82 clinical isolates collected routinely between 1973 and 2013. If novel, presently unclear or resistance-related mutations were found, the resistance phenotype against acyclovir (ACV) and foscarnet (FOS) was analyzed. The four novel amino acid changes G150D, A157T, R248W, L342W and the hitherto phenotypically unclear substitution T131M within the TK gene were identified as natural polymorphisms. Within the DNA pol gene, 17 novel substitutions and the to-date unclear change R628C were characterized as part of natural gene polymorphism. Two novel DNA pol mutations were linked to resistance (M910T) and weak susceptibility to ACV (684 insertion ED), respectively. In one isolate, the genomic cause of ACV resistance could not be identified. Phylogenetic analysis including sequences of this study and of the GenBank revealed a hierarchy of mutation clusters in TK displaying G39E as first common mutation step, followed by N78D and L140F. In conclusion, the present...Continue Reading
References
May 1, 1978·Proceedings of the National Academy of Sciences of the United States of America·U B DasGupta, W C Summers
Sep 1, 1988·Proceedings of the National Academy of Sciences of the United States of America·J S GibbsD M Coen
Jul 1, 1982·Antimicrobial Agents and Chemotherapy·D S Parris, J E Harrington
Jan 15, 1984·Virology·J D HallP A Schaffer
Feb 1, 1995·The Journal of Infectious Diseases·T J Jones, R Paul
Feb 1, 1993·Antiviral Research·J T MatthewsA K Field
Sep 1, 1996·The Journal of Infectious Diseases·J J Sasadeusz, S L Sacks
Dec 10, 1999·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·A Alvarez-McLeodK E Drew
May 18, 2000·Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology·A SauerbreiP Wutzler
Mar 10, 2001·Journal of Virology·J Bestman-SmithG Boivin
Jul 24, 2002·Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy·Christian GilbertGuy Boivin
Jan 14, 2003·Archives of Internal Medicine·Michele ReyesUNKNOWN Task Force on Herpes Simplex Virus Resistance
Feb 19, 2003·Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology·Florence Morfin, Danielle Thouvenot
May 29, 2003·The Journal of General Virology·Wendy HarrisGraham Darby
Aug 13, 2003·Bioinformatics·Fredrik Ronquist, John P Huelsenbeck
Dec 13, 2003·Antiviral Research·Doris ChiboChris Birch
Jan 2, 2004·The New England Journal of Medicine·Lawrence CoreyUNKNOWN Valacyclovir HSV Transmission Study Group
Jan 13, 2004·Journal of Clinical Microbiology·C Danve-SzatanekC Zandotti
Feb 25, 2005·Antimicrobial Agents and Chemotherapy·E FrobertF Morfin
Apr 28, 2006·The Journal of Biological Chemistry·Shenping LiuAndrew P Seddon
May 10, 2007·Molecular Biology and Evolution·Koichiro TamuraSudhir Kumar
Mar 10, 2010·Antiviral Research·A SauerbreiP Wutzler
Aug 25, 2010·Antimicrobial Agents and Chemotherapy·Sonia BurrelDavid Boutolleau
Nov 17, 2010·Antimicrobial Agents and Chemotherapy·Jocelyne Piret, Guy Boivin
Oct 26, 2011·Antiviral Therapy·Kathrin BohnAndreas Sauerbrei
Dec 14, 2011·Antiviral Therapy·Andreas SauerbreiKlaus Hamprecht
Oct 1, 2013·Antiviral Research·Sonia BurrelDavid Boutolleau
Apr 22, 2014·Antiviral Research·Axel SchubertAndreas Sauerbrei
Apr 25, 2014·The New England Journal of Medicine·Sonia BurrelDavid Boutolleau
Citations
Sep 14, 2015·International Journal of Medical Microbiology : IJMM·Ulrich VogelMary Slack
May 14, 2016·PloS One·Johanna G MitterreiterWerner J D Ouwendijk
Jan 21, 2016·Antimicrobial Agents and Chemotherapy·Peter J IrelandLynda A Morrison
Oct 5, 2015·The Journal of Antimicrobial Chemotherapy·Andreas SauerbreiRoland Zell
Jun 25, 2019·Chemotherapy·Paul Schnitzler